HQH
Get informed when a big investor buys or sells
+ FollowOvervalued by 0% based on the discounted cash flow analysis.
| Market cap | $1.14 Billion |
|---|---|
| Enterprise Value | $1.14 Billion |
| Dividend Yield | $2.32 (11.61%) |
| Earnings per Share | $1.84 |
| Beta | 0.77 |
| Outstanding Shares | 54,787,028 |
| P/E Ratio | 4.23 |
|---|---|
| PEG | 5.72 |
| Price to Sales | - |
| Price to Book Ratio | 1.0 |
| Enterprise Value to Revenue | 50.51 |
| Enterprise Value to EBIT | 4.19 |
| Enterprise Value to Net Income | 2 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Holdings and activity of institutional investors.
| Ownership % | 23.99%▼ 0.36% |
|---|---|
| Total Invested | $228.93M▼ 7.45% |
| Investors Holding | 125▲ 3.00% |
No data
Tekla Healthcare Investors is a closed-end fund that invests in companies in the healthcare industry.